▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Agilent Technologies Q4 21 Earnings Conference Call At 4:30 PM ET

By RTTNews Staff Writer ✉ | Published: 11/22/2021 6:15 AM ET

Agilent Technologies Inc. (A) will host a conference call at 4:30 PM ET on November 22, 2021, to discuss Q4 21 earnings results.

To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

U.S. Covid Cases Fall 18% In A Fortnight

U.S. Reports 128K New Covid Cases, 464 Deaths

U.S. Reports 10,263 New Covid Cases, 11 Deaths

Roche Unveils Elecsys IGRA SARS-CoV-2 Test In Countries That Accept CE Mark

CDC No Longer Recommends Quarantine, Screening For COVID-19

Read More

COVID-19: Drugs in Development

RELATED NEWS

Agilent Technologies Bottom Line Rises In Q3

Agilent Technologies Q3 22 Earnings Conference Call At 4:30 PM ET

Agilent: FDA Approves TRS100 Method For Content Uniformity Testing By Teva

Agilent Technologies Announces Increase In Q2 Income

Agilent Technologies Q2 22 Earnings Conference Call At 4:30 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Delta To Resume Flights From Los Angeles To Tokyo

Apple Sets Sept. 5 Deadline For Return To Office

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Janus International Reports Profit In Q2

Over 2 Mln MamaRoo, RockaRoo Infant Swings, Rockers Recalled; Death Reported

Walmart+ Members To Get Free Paramount+ Subscription

Fifth Season Recalls Crunchy Sesame Salad Kits

Tesla Produced Over 3 Mln Vehicles, 1 Mln In China: Elon Musk

King's Hawaiian Recalls Pretzel Buns, Bites

Henkel H1 Profit Down, Backs FY22 Adj. Earnings View; Lifts Sales Forecast

Home Run Inn Recalls Frozen Meat Pizza

CDC No Longer Recommends Quarantine, Screening For COVID-19

Lyons Magnus Expands Recall Of Nutritional And Beverage Products

888 Holdings H1 Earnings Fall

Toast Up As Q2 Results Improve; Annual Sales Outlook Raised

UNITY Reports Positive Proof-of-concept Data With UBX1325 In Patients With Diabetic Macular Edema

Deutsche Telekom Lifts FY22 View Despite Weak Q2 Profit; Stock Up

AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For HER2 Mutant Metastatic NSCLC

Disney+ With No Ads To Now Come At $3 Premium Per Month

Johnson & Johnson To Discontinue Talc-based Baby Powder

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%

South Korea Approves Novavax's Nuvaxovid COVID-19 Vaccine For Use In Adolescents

Resmed Inc Q4 sales increase

Home Run Inn Recalls Frozen Meat Pizza

Resmed Inc Q4 sales increase

RWE AG H1 Adj. Net Income Rises

Disney Outshines Netflix On Streaming Subscribers

Witan Investment Posts Loss For H1

Kelly Services Q2 Profit Decreases, misses estimates

U.S. To Get Base Powder For 6 Mln Bottles Of Specialty Formula From Mexico

AstraZeneca: DESTINY-Breast02 Results Confirm Efficacy Seen In Previous Trials Of ENHERTU

Deutsche Telekom Q2 Profit Down, Adj. EBITDA AL Rises; Lifts FY22 Outlook - Quick Facts

Dodge To Stop Operations Of Challenger And Charger Muscle Cars In 2023

AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For HER2 Mutant Metastatic NSCLC

TherapeuticsMD Turns To Profit In Q2 - Quick Facts